China's humanoid robot industry, which shipped 90% of the world's units in 2025, is facing a harsh reality check as new data reveals that only 23% of buyers report being satisfied with their purchases. The sector now hosts over 150 companies, yet consumer sentiment has soured amid high costs, limited functionality, and inconsistent reliability.
“We are seeing a massive disconnect between production volume and real-world performance,” said Dr. Li Wei, a robotics analyst at the Beijing Institute of Technology. “Many companies are rushing to market with prototypes that fail to meet basic expectations, leading to widespread buyer regret.”
Despite the dissatisfaction, the two largest manufacturers—Unitree and AgiBot—are preparing initial public offerings that collectively value them at $13 billion. Morgan Stanley recently doubled its 2025 delivery forecast for the Chinese market, expecting continued growth even as quality issues persist.
Background
China’s humanoid robot industry exploded in the wake of government subsidies and strategic investments aimed at dominating the global robotics supply chain. From startups to state-backed enterprises, the race to produce walking, talking machines has attracted billions in capital.
Yet the rapid expansion has come at a cost. Many products lack the dexterity and AI capabilities advertised, with breakdowns and limited task performance frustrating early adopters. A survey from the China Robotics Industry Alliance found that over 60% of users cited price and functionality as primary pain points.
What This Means
The low satisfaction rate signals a potential market correction. Investors who poured money into these firms may face a reckoning if customer retention fails to improve. “The industry is at a crossroads,” warned Sarah Chen, senior equity analyst at Asia Robotics Capital. “If companies don’t pivot toward reliability and real-world utility, the IPO euphoria could turn into a bust.”
For consumers, the message is clear: buyer beware. While prices are expected to drop as production scales, the current generation of humanoid robots remains a novelty rather than a practical investment. The next 12 months will be critical for firms like Unitree and AgiBot to demonstrate improvements or risk losing market confidence.
Internationally, China’s struggles could open doors for competitors in Japan, the US, and Europe, who have prioritized slower, more iterative development. “Quality over quantity is the lesson here,” added Chen. “The long-term winners will be those who perfect the software and hardware integration first.”